Loebel Antony has filed 3 insider transactions across 1 company since April 2026.
Most recent transaction: a transaction of 20109 shares of Seaport Therapeutics, Inc. ($SPTX) on May 04, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 4, 2026 | Seaport Therapeutics, Inc. | $SPTX | Loebel Antony | Chief Medical Officer | C | Common Stock | 20109 | $0.00 | 20,109.0000 | 0 | 9999.99% | 0.00% |
| April 30, 2026 | Seaport Therapeutics, Inc. | $SPTX | Loebel Antony | Chief Medical Officer | A | Stock Option (Right to Buy) | 63680 | $0.00 | 63,680.0000 | 0 | 9999.99% | 0.00% |
| May 4, 2026 | Seaport Therapeutics, Inc. | $SPTX | Loebel Antony | Chief Medical Officer | C | Series B Preferred Stock | 63157 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |